Loading…
Loading…
Contract Research Organization (CRO) offering comprehensive clinical research and development services to…
Pepgra is a Contract Research Organization (CRO) offering comprehensive clinical research and development services to pharmaceutical, biotechnology, and medical device companies. The company specializes in clinical research and field monitoring, biostatistics and clinical data management, regulatory writing, and regulatory affairs consultation. Pepgra employs a hybrid approach that combines therapeutic realignment with regionally based clinical research associates to build optimized monitoring teams for each study.
Pepgra's regulatory writing team is certified by both the American Medical Writers Association (AMWA) and the European Medical Writers Association (EMWA), ensuring strict adherence to international protocols including ICH, FDA, EU, and GCP guidelines. The company's expertise spans a wide range of domains including prescription drugs, medical devices, over-the-counter medicines, biologics, nutraceuticals, veterinary medicines, and cosmetics, supported by PhD-level professionals in pharma, medicine, life sciences, and biotechnology.
Positioned as a flexible, affordable, and scalable CRO partner, Pepgra fulfills critical gaps in sponsor organizations' capabilities — including personnel, technology, and specialized facilities — without requiring sponsors to expand their own resources. With offices serving both Indian and UK markets, Pepgra leverages local regulatory familiarity and established site networks to deliver time and cost savings throughout the clinical development and approval process.
No products listed yet
Explore Other CompaniesClaim this listing to manage your profile, add products, and connect with buyers.
Leave your details and we'll pass them on when the company activates their listing.
Buyers researching pepgra health care pvt ltd also reference the India halal-industry profile for market context, and our Halal Supplier Sourcing Guide for vetting, RFQ, and trade-show due-diligence playbooks.